A director at Mega Fortris Berhad sold 450,000 shares at 0.810MYR and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Two Directors at IOI Properties Group Berhad bought/sold 9,987,800 shares at between 3.586MYR and 3.587MYR. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's...
A director at FPT Corporation sold 300,000 shares at 0.000VND and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
In H1:2025, Nigeria experienced its first taste of macroeconomic stability since 2023, and in our H2:2025 outlook, we asked key questions about how sustainable this recovery could be, given the starting point: inflation in the 30% range, the exchange rate hovering around NGN1,600/USD, weak FX reserves, and extraordinarily high fixed-income yields. Yet 2025 brought a breath of fresh air, and 2026 has the potential to turn this stability into a new norm, if we can effectively seize the gains from ...
The Bulgarian equity market experienced notable intraday volatility in the final trading session of the week, driven by low-volume price swings across a broad range of stocks. Despite these fluctuations, the major indices finished largely unchanged, leaving week-to-date performance broadly flat. SOFIX (1 353.00) closed at the same level as gains in Central Cooperative Bank (CCB, EUR 1.88, +3.30%) and Chimimport (CHIM, EUR 0.49, +4.26%) fully offset declines in Doverie (DUH, EUR 6.90, -2.54%), Fi...
Forløb af ekstraordinær generalforsamling Selskabsmeddelelse nr. 09/2026København, den 23. februar 2026 Tirsdag den 23. februar 2026 kl. 10.00 blev der afholdt ekstraordinær generalforsamling i Unlimit Group A/S med følgende dagsorden: Valg af dirigent.Gennemførelse af ændring af aktiernes stykstørrelse (aktiesammenlægning/omvendt aktiesplit) fra kr. 0,01 til kr. 10 med forholdet 1.000:1.Valg af ny revisor.Vedtagelse af nye vedtægter.Eventuelt. AD. punkt 1Generalforsamlingen valgte Christoffer Friis til dirigent. AD. punkt 2Generalforsamlingen godkendte forslaget om gennemførsel af ændr...
Harvia completed repurchase of own shares Harvia Plc, Stock Exchange Release, February 23, 2026 at 12:00 pm EET Harvia has completed the repurchase of own shares, which started on 19 February 2026 and ended on 20 February 2026. During that time, Harvia acquired a total of 17,000 own shares for an average price of EUR 39,009 per share. The repurchased shares were acquired based on the authorization given by the Annual General Meeting on 8 April 2025 and shall be used as a part of the Company’s incentive program. Following the repurchase, Harvia Plc holds a total of 20,800 own shares, cor...
Harvia on saanut päätökseen omien osakkeidensa hankinnan Harvia Oyj, Pörssitiedote, 23.2.2026 klo 12:00 Harvia Oyj on saanut päätökseen omien osakkeidensa hankinnan, joka alkoi 19.2.2026 ja päättyi 20.2.2026. Tänä aikana Harvia hankki 17 000 omaa osaketta keskihintaan 39,009 euroa osakkeelta. Osakkeet hankittiin Nasdaq Helsinki Oy:n järjestämässä julkisessa kaupankäynnissä hankintahetken markkinahintaan. Osakkeiden hankinta perustui varsinaisen yhtiökokouksen 8.4.2025 antamaan valtuutukseen ja osakkeet käytetään osana yhtiön kannustinjärjestelmää. Hankinnan jälkeen Harvia Oyj:llä ...
After two years of steep losses and a tough macro environment that pressured volumes, Nigerian Breweries’ 2025FY results reveal a company that has not only planned its way back to profitability but also emerged with a stronger balance sheet, a more resilient earnings model, and a clearer strategic focus. Beyond the headline NGN99.1bn profit after tax, the rebound was driven by tighter cost discipline, sharply lower finance costs, and internal restructuring measures, including the shutdown of un...
Novo Nordisk A/S: CagriSema demonstrated 23% weight loss in an open-label head-to-head REDEFINE 4 trial in people with obesity, the primary endpoint was not achieved CagriSema achieved 23% weight loss after 84 weeks of treatmentCagriSema 2.4/2.4 mg did not meet the primary endpoint of showing non-inferiority on weight loss compared to tirzepatide 15 mg at 84 weeks1Additional trials are exploring the full weight loss potential of CagriSema, including higher-dose combinations Bagsværd, Denmark, 23 February 2026 – Novo Nordisk today announced headline results from REDEFINE 4, an open-label ph...
Déclaration hebdomadaire des transactions sur CCI 2026 02 16 - 2026 02 20 CAISSE RÉGIONALE DE CRÉDIT AGRICOLE MUTUEL TOULOUSE 31 Siège Social : 6-7 Place Jeanne d’Arc – 31000 TOULOUSE SIREN 776 916 207 RCS TOULOUSE Société Coopérative à capital variable créée le 18 janvier 1901, régie par le Livre V du Code Monétaire et Financier.Établissement de crédit agréé en qualité de banque mutualiste ou coopérative. Société de courtage d'assurances.Garantie financière et assurance de responsabilité civile professionnelle conformes aux articles L.512-6 et L.512-7 du Code des assurances. ...
A director at Private Equity Holding AG bought 600 shares at 61.000CHF and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
4Q'25 vs. 4Q'24 Results Sales: € 287.4 M (+11.4% vs. +10.7% BS(e) and +10.3% consensus); EBITDA: € 52.2 M (+3.6% vs. +4.0% BS(e) and +4.8% consensus); EBIT: € 14.3 M (-4.7% vs. +2.7% BS(e) and +14.0% consensus); Net Profit: € 7.1 M (+3450.0% vs. +3447.5% BS(e) and +3650.0% consensus); FY2025 vs. FY2024 Results Sales: € 1.108 Bn (+12.4% vs. +12.3% BS(e) and +12.1% consensus); EBITDA: € 232.9 M (+20.9% vs. +21.0% BS(e) and +21.2% consensus); EBIT: € 81.7 M (+52.7% vs. +54.8% BS(e) and +57.9% conse...
A director at Genolution Inc bought 810,372 shares at 1,818.000KRW and the significance rating of the trade was 86/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
A director at Sugs Lloyd Ltd bought 28,000 shares at 99.170INR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.